concizumab-mtci (Alhemo)
Jump to navigation
Jump to search
Indications
- prophylaxis to prevent or reduce the frequency of bleeding episodes in adults & adolecents >= 12 years of age with:
- hemophilia A with factor VIII inhibitors
- hemophilia B with factor IX inhibitors
Dosage
- Day 1: Loading dose of 1 mg/kg
- Day 2: Once-daily dose of 0.2 mg/kg until individualization of maintenance dose (see HIGHLIGHTS OF PRESCRIBING INFORMATION)[2]
Mechanism of action
More general terms
References
- ↑ Alhemo NovoMedlink Rare Bleeding Disorders https://www.novomedlink.com/rare-bleeding-disorders/products/treatments/alhemo.html
- ↑ Jump up to: 2.0 2.1 HIGHLIGHTS OF PRESCRIBING INFORMATION Alhemo <TM> (concizumab-mtci) injection, for subcutaneous use https://www.novo-pi.com/alhemo.pdf